监测血糖的生物传感器系统
|
By LabMedica International staff writers Posted on 02 Feb 2018 |
|
图片：为无创监测血液葡萄糖而开发的皮肤样生物传感器系统（图片蒙清华大学惠赐）。
目前，无创监测葡萄糖测量值、准确性不稳定，与血糖关联度弱，且不能检测睡眠时的高血糖/低血糖，所以还未广为人知。
对糖尿病患者进行受控的连续葡萄糖监测(CGM)能更好地监测和控制血糖水平，并预防并发症，而市售的产品监测葡萄糖需要用创伤性的针刺手段。
清华大学的科学家研制了一款皮肤样的生物传感器系统，用于无创原位静脉内血糖监测。该系统集成了一只超薄皮肤样生物传感器与纸电池供电的电化学双通道(ETC)。特制的皮下ETC把血糖压出血管，运送到皮肤表面。
超薄（约3微米）纳米结构生物传感器灵敏度高(130.4 μA/mM)，顺应性极强，能完全吸收和测量葡萄糖。这种超薄皮肤样生物传感器能完全贴合皮肤，测量受ETC驱动向外运动的葡萄糖。这些生物传感器是多层的“沙丘”状纳米结构，表现出更好的电化学特性和更高的灵敏度。
科研小组进行了人体临床实验。用市售的罗氏公司的ACCU-CHEK Performa血糖计和静脉留置针做创伤性的葡萄糖测量。用无创的皮肤样血糖监测系统测量静脉内血糖和组织间液(ISF)里的血糖。ETC极大提高了无创测量结果与真实血糖水平之间的关联。该系统经过正确校准后有望适用于医用级CGM，与微型胰岛素泵配套使用时可实施胰岛素疗法。该研究的论文发表于2017年12月1日的《科学进展》(Science Advances)杂志。
Related Links:
清华大学
罗氏公司
 (3) (1).png)
对糖尿病患者进行受控的连续葡萄糖监测(CGM)能更好地监测和控制血糖水平，并预防并发症，而市售的产品监测葡萄糖需要用创伤性的针刺手段。
清华大学的科学家研制了一款皮肤样的生物传感器系统，用于无创原位静脉内血糖监测。该系统集成了一只超薄皮肤样生物传感器与纸电池供电的电化学双通道(ETC)。特制的皮下ETC把血糖压出血管，运送到皮肤表面。
超薄（约3微米）纳米结构生物传感器灵敏度高(130.4 μA/mM)，顺应性极强，能完全吸收和测量葡萄糖。这种超薄皮肤样生物传感器能完全贴合皮肤，测量受ETC驱动向外运动的葡萄糖。这些生物传感器是多层的“沙丘”状纳米结构，表现出更好的电化学特性和更高的灵敏度。
科研小组进行了人体临床实验。用市售的罗氏公司的ACCU-CHEK Performa血糖计和静脉留置针做创伤性的葡萄糖测量。用无创的皮肤样血糖监测系统测量静脉内血糖和组织间液(ISF)里的血糖。ETC极大提高了无创测量结果与真实血糖水平之间的关联。该系统经过正确校准后有望适用于医用级CGM，与微型胰岛素泵配套使用时可实施胰岛素疗法。该研究的论文发表于2017年12月1日的《科学进展》(Science Advances)杂志。
Related Links:
清华大学
罗氏公司
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Gel Cards
DG Gel Cards
Pipette
Accumax Smart Series
Latest 临床化学 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more